ArticleHematology reports2026

Diminished Prognostic Value of Interim PET in Hodgkin Lymphoma Treated with Brentuximab Vedotin Plus AVD: A Retrospective Analysis.

Kareem Latif et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.